Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Cliff JM, King EC, Lee JS, Sepúlveda N, Wolf AS, Kingdon C, Bowman E, Dockrell HM, Nacul L, Lacerda E, Riley EM.

Front Immunol. 2019 Apr 16;10:796. doi: 10.3389/fimmu.2019.00796. eCollection 2019.

2.

Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study.

Nacul L, de Barros B, Kingdon CC, Cliff JM, Clark TG, Mudie K, Dockrell HM, Lacerda EM.

Diagnostics (Basel). 2019 Apr 10;9(2). pii: E41. doi: 10.3390/diagnostics9020041.

3.

Metformin alters human host responses to Mycobacterium tuberculosis in healthy subjects.

Lachmandas E, Eckold C, Böhme J, Koeken VACM, Marzuki MB, Blok B, Arts RJW, Chen J, Teng KWW, Ratter J, Smolders EJ, van den Heuvel C, Stienstra R, Dockrell HM, Newell E, Netea MG, Singhal A, Cliff JM, van Crevel R.

J Infect Dis. 2019 Feb 12. doi: 10.1093/infdis/jiz064. [Epub ahead of print]

PMID:
30753544
4.

Hope, disappointment and perseverance: Reflections of people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis participating in biomedical research. A qualitative focus group study.

Lacerda EM, McDermott C, Kingdon CC, Butterworth J, Cliff JM, Nacul L.

Health Expect. 2019 Jan 10. doi: 10.1111/hex.12857. [Epub ahead of print]

PMID:
30632248
5.

Host Gene Expression Kinetics During Treatment of Tuberculosis in HIV-Coinfected Individuals Is Independent of Highly Active Antiretroviral Therapy.

Gebremicael G, Kassa D, Quinten E, Alemayehu Y, Gebreegziaxier A, Belay Y, van Baarle D, Ottenhoff THM, Cliff JM, Haks MC.

J Infect Dis. 2018 Oct 20;218(11):1833-1846. doi: 10.1093/infdis/jiy404.

PMID:
29982697
6.

Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis.

Chegou NN, Sutherland JS, Namuganga AR, Corstjens PL, Geluk A, Gebremichael G, Mendy J, Malherbe S, Stanley K, van der Spuy GD, Kriel M, Loxton AG, Kriel B, Simukonda F, Bekele Y, Sheehama JA, Nelongo J, van der Vyver M, Gebrexabher A, Hailu H, Esterhuyse MM, Rosenkrands I, Aagard C, Kidd M, Kassa D, Mihret A, Howe R, Cliff JM, Crampin AC, Mayanja-Kizza H, Kaufmann SHE, Dockrell HM, Ottenhoff THM, Walzl G; AE-TBC consortium.

Sci Rep. 2018 Feb 8;8(1):2675. doi: 10.1038/s41598-018-20855-7.

7.

The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis.

Lacerda EM, Bowman EW, Cliff JM, Kingdon CC, King EC, Lee JS, Clark TG, Dockrell HM, Riley EM, Curran H, Nacul L.

Open J Bioresour. 2017;4. pii: 4. doi: 10.5334/ojb.28. Epub 2017 Feb 20.

8.

Primary macrophages and J774 cells respond differently to infection with Mycobacterium tuberculosis.

Andreu N, Phelan J, de Sessions PF, Cliff JM, Clark TG, Hibberd ML.

Sci Rep. 2017 Feb 8;7:42225. doi: 10.1038/srep42225.

9.

Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease.

Awoniyi DO, Teuchert A, Sutherland JS, Mayanja-Kizza H, Howe R, Mihret A, Loxton AG, Sheehama J, Kassa D, Crampin AC, Dockrell HM, Kidd M, Rosenkrands I, Geluk A, Ottenhoff TH, Corstjens PL, Chegou NN, Walzl G; AE-TBC Consortium.

J Infect. 2016 Sep;73(3):219-30. doi: 10.1016/j.jinf.2016.04.036. Epub 2016 Jun 14.

10.

Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.

Chegou NN, Sutherland JS, Malherbe S, Crampin AC, Corstjens PL, Geluk A, Mayanja-Kizza H, Loxton AG, van der Spuy G, Stanley K, Kotzé LA, van der Vyver M, Rosenkrands I, Kidd M, van Helden PD, Dockrell HM, Ottenhoff TH, Kaufmann SH, Walzl G; AE-TBC consortium.

Thorax. 2016 Sep;71(9):785-94. doi: 10.1136/thoraxjnl-2015-207999. Epub 2016 May 4.

11.

PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment.

Hassan SS, Akram M, King EC, Dockrell HM, Cliff JM.

PLoS One. 2015 Sep 11;10(9):e0137646. doi: 10.1371/journal.pone.0137646. eCollection 2015.

12.

Excessive Cytolytic Responses Predict Tuberculosis Relapse After Apparently Successful Treatment.

Cliff JM, Cho JE, Lee JS, Ronacher K, King EC, van Helden P, Walzl G, Dockrell HM.

J Infect Dis. 2016 Feb 1;213(3):485-95. doi: 10.1093/infdis/jiv447. Epub 2015 Sep 7.

13.

Mycobacterial load affects adenosine deaminase 2 levels of tuberculous pleural effusion.

Kim CH, Lee J, Lee J, Cliff JM, Toulza F, Smith S, Yoo SS, Lee SY, Cha SI, Park JY, Dockrell HM.

J Infect. 2015 Oct;71(4):488-91. doi: 10.1016/j.jinf.2015.05.015. Epub 2015 Jun 3. No abstract available.

PMID:
26049138
14.

The human immune response to tuberculosis and its treatment: a view from the blood.

Cliff JM, Kaufmann SH, McShane H, van Helden P, O'Garra A.

Immunol Rev. 2015 Mar;264(1):88-102. doi: 10.1111/imr.12269. Review.

15.

TANDEM: understanding diabetes and tuberculosis.

van Crevel R, Dockrell HM; TANDEM Consortium.

Lancet Diabetes Endocrinol. 2014 Apr;2(4):270-2. doi: 10.1016/S2213-8587(14)70011-7. Epub 2014 Mar 24. No abstract available.

PMID:
24703039
16.

Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure.

Hassan SS, Cho JE, Akram M, Fielding KL, Dockrell HM, Cliff JM.

PLoS One. 2013 Jul 26;8(7):e70063. doi: 10.1371/journal.pone.0070063. Print 2013.

17.

Recombinant ESAT-6-CFP10 Fusion Protein Induction of Th1/Th2 Cytokines and FoxP3 Expressing Treg Cells in Pulmonary TB.

Jackson-Sillah D, Cliff JM, Mensah GI, Dickson E, Sowah S, Tetteh JK, Addo KK, Ottenhoff TH, Bothamley G, Dockrell HM.

PLoS One. 2013 Jun 27;8(6):e68121. doi: 10.1371/journal.pone.0068121. Print 2013.

18.

Long-lived memory B-cell responses following BCG vaccination.

Sebina I, Cliff JM, Smith SG, Nogaro S, Webb EL, Riley EM, Dockrell HM, Elliott AM, Hafalla JC, Cose S.

PLoS One. 2012;7(12):e51381. doi: 10.1371/journal.pone.0051381. Epub 2012 Dec 11.

19.

Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response.

Cliff JM, Lee JS, Constantinou N, Cho JE, Clark TG, Ronacher K, King EC, Lukey PT, Duncan K, Van Helden PD, Walzl G, Dockrell HM.

J Infect Dis. 2013 Jan 1;207(1):18-29. doi: 10.1093/infdis/jis499. Epub 2012 Aug 7.

PMID:
22872737
20.

CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.

Hasan Z, Cliff JM, Dockrell HM, Jamil B, Irfan M, Ashraf M, Hussain R.

PLoS One. 2009 Dec 29;4(12):e8459. doi: 10.1371/journal.pone.0008459.

Supplemental Content

Loading ...
Support Center